NASH and Liver Cancer: The New Cancer Headline

GLI-news-banner.png

Of the many causes of liver cancer NASH has emerged as a significant contributor to this disease. GLI's President & CEO Donna Cryer connects the dots between NASH and liver cancer in this cover article in this month's American Journal of Managed Care's Evidence Based Oncology.

Read the article...

Press ReleasesDonna Cryer